Table 2 Clinical findings in 8 patients
Sings and symptoms | P01 | P02 | P03 | P04 | P05 | P06 | P07 | P08 |
|---|---|---|---|---|---|---|---|---|
Gender | male | male | female | female | male | female | male | female |
Age (year) | 12 | 28 | 34 | 36 | 47 | 42 | 42 | 47 |
Nyctalopia time | First decade | First decade | First decade | First decade | First decade | First decade | First decade | First decade |
Course of disease (year) | 5 | 25 | 30 | 30 | 40 | 35 | 35 | 40 |
BCVA (logMAR) OD | 0.4 | 0.1 | 0.5 | 0.2 | HM | 1/35 at 1 m | 0.4 | HM |
BCVA (logMAR) OS | 0.5 | 0.1 | 0.5 | 0.3 | HM | 0.4 | 0.4 | HM |
bone-spicule pigmentation | – | – | + | + | + | + | + | + |
ERM | – | + | + | + | + | + | – | + |
CME | – | – | + | – | – | – | – | – |
Macular atrophy | – | – | + | – | + | + | + | + |
PSAWM | – | – | + | – | – | – | – | – |
Lamellar macular hole | – | – | + | – | – | – | – | – |
CST (um) OD | 296 | 224 | 169 | 229 | 419 | 138 | 181 | NA |
CST (um) OS | NA | 229 | 366 | 215 | 193 | 134 | 221 | NA |